Correlation Between Scholar Rock and Armata Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scholar Rock and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scholar Rock and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scholar Rock Holding and Armata Pharmaceuticals, you can compare the effects of market volatilities on Scholar Rock and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scholar Rock with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scholar Rock and Armata Pharmaceuticals.

Diversification Opportunities for Scholar Rock and Armata Pharmaceuticals

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Scholar and Armata is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Scholar Rock Holding and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Scholar Rock is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scholar Rock Holding are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Scholar Rock i.e., Scholar Rock and Armata Pharmaceuticals go up and down completely randomly.

Pair Corralation between Scholar Rock and Armata Pharmaceuticals

Given the investment horizon of 90 days Scholar Rock Holding is expected to generate 4.5 times more return on investment than Armata Pharmaceuticals. However, Scholar Rock is 4.5 times more volatile than Armata Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Armata Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest  1,880  in Scholar Rock Holding on August 25, 2024 and sell it today you would earn a total of  1,112  from holding Scholar Rock Holding or generate 59.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Scholar Rock Holding  vs.  Armata Pharmaceuticals

 Performance 
       Timeline  
Scholar Rock Holding 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Scholar Rock Holding are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Scholar Rock disclosed solid returns over the last few months and may actually be approaching a breakup point.
Armata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Armata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Armata Pharmaceuticals is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Scholar Rock and Armata Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scholar Rock and Armata Pharmaceuticals

The main advantage of trading using opposite Scholar Rock and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scholar Rock position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.
The idea behind Scholar Rock Holding and Armata Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like